The importance of CD8+ T cell-mediated tumor control through pMHC-I:TCR interactions is highlighted by the observation that MHC-I or β2M loss in tumor cells—both resulting in the absence of antigen presentation on the cancer cells surface—leads to tumor immune evasions and subsequent tumor outgrowth in patients21,22. The gene discussed is CD8A; the disease is cancer.